Lenacapavir
CAS: 2189684-44-2
Ref. TM-T11465
| 1mg | 310.00 € | ||
| 5mg | 641.00 € | ||
| 10mg | 1,050.00 € | ||
| 25mg | 1,551.00 € | ||
| 50mg | 2,089.00 € | ||
| 100mg | 2,757.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Product Information
Name:
Lenacapavir
Synonyms:
- GS-6207
Description:
Lenacapavir (GS-6207) is the first HIV-1 capsid inhibitor approved by the U.S. Food and Drug Administration, the European Medicines Agency, and Health Canada for the treatment of MDR HIV-1 infection.Cost-effective and quality-assured.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
968.28
Formula:
C39H32ClF10N7O5S2
Purity:
100.00% - 99.61%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T11465 Lenacapavir
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
